Clinical Trial Update: Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

View source ↗

Summary

A completed clinical trial evaluates the safety of an investigational oral resin for treating hyperkalemia in Chinese patients with renal insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Oral resin (investigational)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia | Status: COMPLETED